Abstract
Background The HEalth and Ageing Data IN the Game of football (HEADING) study assessed the associations between exposure to heading a football, other impacts to the head, and concussions, with cognitive function, among former professional soccer players in England.
Methods Recruitment of former male professional soccer players aged 50+ years was conducted through the English Professional Footballers’ Association. Cumulative exposure to heading and other impacts to the head was estimated from the playing history questionnaire. Concussion was self-reported and assessed with the BRAIN-Q tool. The primary outcome was cognitive function measured with the Preclinical Alzheimer Cognitive Composite (PACC).
Findings Data for a total of 199 males were available for analysis. No overall association was found between heading and/or other impacts to the head and cognitive function. Amongst forwards only, those in the fourth (highest) quartile of exposure to other impacts to the head had a significantly lower PACC score compared to those in the first quartile (• = -0.65, 95% C.I. -1.23, -0.07). For all players, self-reported concussions were associated with slightly lower cognitive function (• = -0.01; 95% C.I. -0.01, -0.001).
Interpretation This study generally does not support an association between exposure to heading a football and poorer cognitive function among former male professional players. However, an association between the number of concussions sustained and poorer cognitive function was present, although the effect size is relatively small.
Funding This study was funded with a grant of the Drake Foundation to the London School of Hygiene and Tropical Medicine.
Evidence before this study There is increasing evidence for an association between sport-related concussion and poorer cognitive function later in life, in former athletes. In soccer, heading the ball is a common event, particularly for outfield players, and involves repetitive sub-concussive impacts. The association between exposure to heading and cognitive function later in life is not consistent in the literature.
Added value of this study This study is the first to provide appropriately modelled exposure estimates of both heading the ball and other impacts to the head among soccer players. Our findings do not support an association between heading and poorer cognitive function later in life. However they do suggest an association between concussion and poorer cognitive function among soccer players, although the size of the effect is relatively small. Other impacts to the head, such as head-to-head collisions, that did not result in the clinical features of concussions were also shown to be associated with poorer cognitive function, but only among forwards.
Implication of the available evidence These findings support a continuous focus on the prevention of concussion in all sports, including soccer, whilst the consequences of repeated exposure to head impacts need to be further explored. Methodologically, it would be advisable to harmonise the tools developed to estimate cumulative exposures to heading, to other head impacts, and to sport-related concussion, to increase comparability of results across studies, thus enabling a sound synthesis of the evidence.
Competing Interest Statement
Conflict of interest statement: HZ has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Alzecure, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). HZ is a Wallenberg Scholar and a Distinguished Professor at the Swedish Research Council supported by grants from the Swedish Research Council (#2023-00356; #2022-01018 and #2019-02397), the European Union Horizon Europe research and innovation programme under grant agreement No 101053962, Swedish State Support for Clinical Research (#ALFGBG-71320), the Alzheimer Drug Discovery Foundation (ADDF), USA (#201809-2016862), the AD Strategic Fund and the Alzheimer Association (#ADSF-21-831376-C, #ADSF-21-831381-C, #ADSF-21-831377-C, and #ADSF-24-1284328-C), the Bluefield Project, Cure Alzheimer Fund, the Olav Thon Foundation, the Erling-Persson Family Foundation, Stiftelsen for Gamla Tjanarinnor, Hjarnfonden, Sweden (#FO2022-0270), the European Union Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 860197 (MIRIADE), the European Union Joint Programme Neurodegenerative Disease Research (JPND2021-00694), the National Institute for Health and Care Research University College London Hospitals Biomedical Research Centre, and the UK Dementia Research Institute at UCL (UKDRI-1003).
Funding Statement
Funding: This study was funded by a grant from the Drake Foundation (www.drakefoundation.org/) to the London School of Hygiene and Tropical Medicine (NP) (EPMSZ06110), with subcontracts to Queen Mary University of London (QMUL) (VG) and the Institute of Occupational Medicine (IOM) (DM). All co-authors are co-investigators of the BRAIN Study. SK is employed by the Rugby Football Union as their Medical Services Director.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Ethical Committee of the London School of Hygiene and Tropical Medicine (EC/16282).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* joint last authors
Data Availability
Data sharing Pseudonymised data may be made available on request to external researchers for additional analyses meeting the scientific and ethical standards under which the data was collected, and consistent with the overall aims of the project. If such requests are approved, these additional analyses would be done in collaboration with the study team, and only after approval of the Independent Oversight Committee for the study, and after additional ethical approved, if required.
